Tumour tissue selectivity in the uptake and retention of SN 28049, a new topoisomerase II-directed anticancer agent

Author： Lukka Pradeep Chen Ying Finlay Graeme Joseph Wayne Richardson Emma Paxton James Baguley Bruce

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.72, Iss.5, 2013-11, pp. : 1013-1022

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A Natural Anticancer Agent Thaspine Targets Human Topoisomerase IB

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 2, 2013-02 ,pp. : 356-363

Bentham Science Publishers

Access to resources Recommend Favorite

Retention of activity by the new generation platinum agent AMD0473 in four human tumour cell lines possessing acquired resistance to oxaliplatin

By Sharp S.Y. O'Neill C.F. Rogers P. Boxall F.E. Kelland L.R.

European Journal of Cancer, Vol. 38, Iss. 17, 2002-11 ,pp. : 2309-2315

Elsevier

Access to resources Recommend Favorite

The role of topoisomerases and RNA transcription in the action of the antitumour benzonaphthyridine derivative SN 28049

By Bridewell David Porter Andrew Finlay Graeme Baguley Bruce

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 5, 2008-10 ,pp. : 753-762

Springer Publishing Company

Access to resources Recommend Favorite

Design of New Anti-Cancer Agents Based on Topoisomerase Poisons Targeted to Specific DNA Sequences

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 1, Iss. 3, 2001-01 ,pp. : 219-235

Bentham Science Publishers

Access to resources Recommend Favorite

Etoposide, Topoisomerase II and Cancer

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 4, 2005-01 ,pp. : 363-372

Bentham Science Publishers

Access to resources Recommend Favorite